These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 14513059)

  • 61. Insights into the stem cells of chronic myeloid leukemia.
    Sloma I; Jiang X; Eaves AC; Eaves CJ
    Leukemia; 2010 Nov; 24(11):1823-33. PubMed ID: 20861912
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Expression of a multidrug resistance gene in blast crisis of chronic myelogenous leukemia.
    Pirker R; Goldstein LJ; Ludwig H; Linkesch W; Lechner C; Gottesman MM; Pastan I
    Cancer Commun; 1989; 1(2):141-4. PubMed ID: 2639725
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Extramedullary blast crisis in a patient with chronic myelogenous leukemia in complete cytogenetic and molecular remission on interferon-alpha therapy.
    Beedassy A; Topolsky D; Styler M; Crilley P
    Leuk Res; 2000 Aug; 24(8):733-5. PubMed ID: 10936425
    [TBL] [Abstract][Full Text] [Related]  

  • 64. BCR-ABL1- and CBFB-MYH11-positive chronic myeloid leukemia presenting with primary blast crisis and marrow fibrosis.
    Kidoguchi K; Kojima K; Yokoo M; Kimura S
    Ann Hematol; 2019 Oct; 98(10):2461-2462. PubMed ID: 31399807
    [No Abstract]   [Full Text] [Related]  

  • 65. Unmodified phosphodiester antisense oligodeoxynucleotides to the BCR-ABL junction do not suppress Philadelphia-positive clonogenic cells.
    Käbisch A; Pérènyi L; Seay U; Lohmeyer J; Pralle H
    Acta Haematol; 1994; 92(4):190-6. PubMed ID: 7701917
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Detection of the molecular abnormality in chronic myeloid leukemia by use of the polymerase chain reaction.
    Dobrovic A; Trainor KJ; Morley AA
    Blood; 1988 Dec; 72(6):2063-5. PubMed ID: 3143430
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A case of M-BCR-rearranged, Philadelphia-positive AML that relapsed as chronic phase CML.
    Morgan GJ; Wiedemann LM; Chan LC; Price CM; Kanfer EJ; Galton DA
    Blood; 1990 Jan; 75(1):317-8. PubMed ID: 2403819
    [No Abstract]   [Full Text] [Related]  

  • 68. Do transcriptionally silent BCR-ABL cells persist in CML patients in molecular remission after stem cell transplantation?
    Moravcová J; Nádvorníková S; Sieglová Z; Formánková R; Krsková T; Dvoráková R; Brdicka R
    Leukemia; 2001 Jun; 15(6):997-9. PubMed ID: 11417494
    [No Abstract]   [Full Text] [Related]  

  • 69. Molecular defects associated with the acute phase CML.
    Serra A; Guerrasio A; Gaidano G; Rosso C; Rege-Cambrin G; Petroni D; Mazza U; Saglio G
    Leuk Lymphoma; 1993; 11 Suppl 1():25-8. PubMed ID: 8251905
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Selective inhibition of leukemia cell proliferation by BCR-ABL antisense oligodeoxynucleotides.
    Szczylik C; Skorski T; Nicolaides NC; Manzella L; Malaguarnera L; Venturelli D; Gewirtz AM; Calabretta B
    Science; 1991 Aug; 253(5019):562-5. PubMed ID: 1857987
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Patterns of BCR breakpoints in patients with coexisting inv(16)(p13.1q22) and t(9;22)(q34;q11.2).
    Bustamante D; Chan KR; Czuchlewski DR; Saadi AA
    Int J Hematol; 2012 Mar; 95(3):324-6. PubMed ID: 22370710
    [No Abstract]   [Full Text] [Related]  

  • 72. An e6a2 BCR-ABL fusion transcript in a CML patient having an iliac chloroma at initial presentation.
    Torres F; Ivanova-Dragoeva A; Pereira M; Veiga J; Rodrigues AS; Sousa AB; Tavares P; Fernandes AR
    Leuk Lymphoma; 2007 May; 48(5):1034-7. PubMed ID: 17487751
    [No Abstract]   [Full Text] [Related]  

  • 73. Nilotinib and allogeneic stem cell transplantation in a chronic myeloid leukemia patient with e6a2 and e1a2 BCR-ABL transcripts.
    Langabeer SE; Crampe M; Kelly J; Fadalla K; Connaghan G; Conneally E
    Leuk Res; 2010 Aug; 34(8):e204-5. PubMed ID: 20346507
    [No Abstract]   [Full Text] [Related]  

  • 74. Chronic myeloid leukemia with p210 BCR-ABL and monocytosis.
    Dass J; Jain S; Tyagi S; Sazawal S
    Leuk Lymphoma; 2011 Jul; 52(7):1380-1. PubMed ID: 21425959
    [No Abstract]   [Full Text] [Related]  

  • 75. BCR-ABL: a multi-faceted promoter of DNA mutation in chronic myelogeneous leukemia.
    Burke BA; Carroll M
    Leukemia; 2010 Jun; 24(6):1105-12. PubMed ID: 20445577
    [TBL] [Abstract][Full Text] [Related]  

  • 76. NPM1 mutations occur rarely or not at all in chronic myeloid leukaemia patients in chronic phase or blast crisis.
    Watkins DB; Hughes TP; White DL; D'Andrea RJ
    Leukemia; 2013 Feb; 27(2):489-90. PubMed ID: 22791379
    [No Abstract]   [Full Text] [Related]  

  • 77. Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia.
    Ahuja H; Bar-Eli M; Advani SH; Benchimol S; Cline MJ
    Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6783-7. PubMed ID: 2771957
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Chronic myelogenous leukemia--the unfolding saga.
    Goldman JM; Grosveld G; Baltimore D; Gale RP
    Leukemia; 1990 Mar; 4(3):163-7. PubMed ID: 2179637
    [No Abstract]   [Full Text] [Related]  

  • 79. Optimizing fusion transcript monitoring in CML.
    Hertzberg M; McDonald D
    Blood; 2007 Mar; 109(5):2263; author reply 2263-4. PubMed ID: 17312000
    [No Abstract]   [Full Text] [Related]  

  • 80. Overproduction of BCR-ABL transcripts in human leukemic cell lines K562 and BV173.
    Moravcová J; Nádvorníková-Muchová S; Brezinová J
    Eur J Haematol; 2000 Feb; 64(2):135-6. PubMed ID: 10997335
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.